We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
-11.73%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$358M
AUM Growth
+$43.1M
(+14%)
Cap. Flow
+$77.7M
Cap. Flow
% of AUM
21.67%
Top 10 Holdings %
Top 10 Hldgs %
35.25%
Holding
226
New
24
Increased
46
Reduced
62
Closed
24
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$17.1M |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$13.5M |
| 3 |
Walmart Inc
WMT
|
+$9.42M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$8.71M |
| 5 |
Microsoft
MSFT
|
+$7.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$1.88M |
| 2 |
Chevron
CVX
|
+$1.45M |
| 3 |
Vail Resorts
MTN
|
+$1.34M |
| 4 |
BSJM
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
|
+$799K |
| 5 |
AbbVie
ABBV
|
+$757K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.11% |
| 2 | Technology | 18.1% |
| 3 | Healthcare | 13.47% |
| 4 | Consumer Staples | 13.16% |
| 5 | Consumer Discretionary | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Cooper Companies
COO
$10.9B
| $3.8M | 1.06% |
48,576
+4
| +0% | +$354 |
2016 Q2
24 quarters
|
|
27
Zoetis
ZTS
$32.4B
| $3.72M | 1.04% |
+21,645
| New | +$3.74M |
2022 Q2
0 quarters
|
|
28
MasTec
MTZ
$15.4B
| $3.59M | 1% |
+50,044
| New | +$3.9M |
2022 Q2
0 quarters
|
|
29
Meta Platforms (Facebook)
META
$1.88T
| $3.58M | 1% |
22,185
-376
| -2% | -$72.5K |
2018 Q1
17 quarters
|
|
30
Charles River Laboratories
CRL
$14.6B
| $3.52M | 0.98% |
16,428
+15,035
| +1,079% | +$3.67M |
2021 Q1
5 quarters
|
|
31
Automatic Data Processing
ADP
$113B
| $3.44M | 0.96% |
16,398
-558
| -3% | -$122K |
2019 Q3
11 quarters
|
|
32
Berkshire Hathaway Class B
BRK.B
$1.13T
| $3.33M | 0.93% |
12,213
-1,500
| -11% | -$471K |
2016 Q2
24 quarters
|
|
33
Costco
COST
$433B
| $3.31M | 0.92% |
+6,912
| New | +$3.51M |
2022 Q2
0 quarters
|
|
34
ExxonMobil
XOM
$718B
| $3.29M | 0.92% |
38,360
-2,876
| -7% | -$259K |
2013 Q4
34 quarters
|
|
35
Church & Dwight Co
CHD
$24.5B
| $3.28M | 0.91% |
35,392
+307
| +0.9% | +$29K |
2019 Q3
11 quarters
|
|
36
Thermo Fisher Scientific
TMO
$258B
| $2.89M | 0.81% |
5,317
+89
| +2% | +$49K |
2020 Q4
6 quarters
|
|
37
Copart
CPRT
$25.7B
| $2.68M | 0.75% |
98,556
-764
| -0.8% | -$21.7K |
2019 Q4
10 quarters
|
|
38
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $2.36M | 0.66% |
6,253
| – | – |
2015 Q4
26 quarters
|
|
|
BSJN
39
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
| $2.34M | 0.65% |
102,184
-20,038
| -16% | -$476K |
2019 Q4
10 quarters
|
|
|
IBDO
40
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $2.33M | 0.65% |
92,925
| – | – |
2019 Q2
12 quarters
|
|
41
Starbucks
SBUX
$110B
| $2.3M | 0.64% |
30,153
+4,027
| +15% | +$309K |
2017 Q3
19 quarters
|
|
42
ARK Genomic Revolution ETF
ARKG
$2.09B
| $2.25M | 0.63% |
71,554
-17,312
| -19% | -$605K |
2020 Q4
6 quarters
|
|
43
Johnson & Johnson
JNJ
$610B
| $2.11M | 0.59% |
11,868
-761
| -6% | -$136K |
2018 Q1
17 quarters
|
|
44
Garmin
GRMN
$55B
| $2.09M | 0.58% |
+21,261
| New | +$2.24M |
2022 Q2
0 quarters
|
|
45
Eli Lilly
LLY
$1.12T
| $1.71M | 0.48% |
5,287
-43
| -0.8% | -$12.9K |
2017 Q4
18 quarters
|
|
46
Spotify
SPOT
$110B
| $1.69M | 0.47% |
+18,051
| New | +$2.04M |
2022 Q2
0 quarters
|
|
47
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $1.47M | 0.41% |
58,882
-22,707
| -28% | -$568K |
2017 Q4
18 quarters
|
|
48
American Water Works
AWK
$26.4B
| $1.47M | 0.41% |
9,876
-171
| -2% | -$26.1K |
2018 Q4
14 quarters
|
|
49
Duke Energy
DUK
$92.7B
| $1.43M | 0.4% |
13,372
-234
| -2% | -$25.7K |
2016 Q4
22 quarters
|
|
50
Mercado Libre
MELI
$94.1B
| $1.43M | 0.4% |
2,239
+495
| +28% | +$432K |
2020 Q2
8 quarters
|
|
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q2 2022 Portfolio in Review
As of Q2 2022, Bellecapital held 226 positions worth $358M, up 14% from $315M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Bellecapital deployed $77.7M of net new capital in Q2 2022, opening 24 new positions and adding to 46 existing holdings. Its largest new stake was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 669,939 shares worth $17M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Health Catalyst, an estimated $1.88M trimmed.
- Bellecapital's largest Q2 2022 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 669,939 shares worth $17M.
- Bellecapital added most to Walmart Inc in Q2 2022, an estimated $9.42M increase.
- Bellecapital's biggest Q2 2022 reduction was Health Catalyst, cutting an estimated $1.88M.
- Bellecapital fully exited Chevron in Q2 2022, selling an estimated $1.45M.
- Bellecapital's ten largest holdings make up 35% of its $358M portfolio in Q2 2022.
- Bellecapital opened 24 new positions and closed 24 in Q2 2022.
- Bellecapital's portfolio value rose 14% quarter-over-quarter to $358M.
Based on Bellecapital's 13F filing for Q2 2022, filed 27 Jul 2022.